Review articlePublished 31 Mar 2020
COVID-19 AN EMERGING EPIDEMIC: A REVIEW
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A novel coronavirus disease (COVID-19), triggered by infection with SARS-CoV-2, has flounced across 31 provinces in China and over 195 countries worldwide. The transition from first symptoms to acute respiratory distress syndrome (ARDS) is extremely probable to be due to unrestrained cytokine release. There is a crucial need to classify safe and active drugs for action. Chloroquine (CQ) exhibitions an inhibitory effect. However, the clinical use of CQ can cause severe side effects. Moreover, hydroxyl-chloroquine (HCQ) also exhibits an antiviral effect highly similar to that of CQ, inhibiting the cytokine storm by suppressing T-cell activation. Coronavirus vaccine will be carry after clinical trials ahead in markets.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Harmonized Research in Medical and Health Science
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Om Prakash Agrawal”
- BylineArticles whose byline prints “CK Tyagi”
- BylineArticles whose byline prints “Deenanath Jhade”
